| Literature DB >> 24648650 |
Ebru Yilmaz Yalcinkaya1, Nil Sayıner Caglar1, Betul Tugcu2, Aysegul Tonbaklar3.
Abstract
[Purpose] To evaluate the results of Bobath-based rehabilitation performed at a pediatric cerebral palsy (CP) inpatient clinic.Entities:
Keywords: Bobath; Cerebral palsy; Rehabilitation
Year: 2014 PMID: 24648650 PMCID: PMC3944307 DOI: 10.1589/jpts.26.285
Source DB: PubMed Journal: J Phys Ther Sci ISSN: 0915-5287
Classification of our CP patients (according to European CP follow-up group)1)
| SP type (new classification) | N | % |
| Spastic bilateral | 20 | 71.43 |
| Spastic unilateral | 4 | 14.29 |
| Dyskinetic | 2 | 7.14 |
| Mixed | 2 | 7.14 |
| 28 | 100 |
Classification of our CP patients
| CP type | N | % |
| Spastic diplegic | 13 | 46.4 |
| hemiplegic | 4 | 14.29 |
| quadriplegic | 7 | 25.00 |
| Ataxic | 1 | 3.57 |
| Hypotonic | 1 | 3.57 |
| Mixed | 2 | 7.14 |
| 28 | 100 |
Identification of the problem and rehabilitation starting time in CP patients
| n | % | |
| Identification of the problem before 12 months of age | 20 | 71.4 |
| Identification of the problem after 12 months of age | 8 | 28.6 |
| Starting rehabilitation before 12 months of age | 9 | 32.14 |
| Starting rehabilitation after 12 months of age | 19 | 67.86 |
Diagnosis of CP patients after eye examination
| Diagnosis | Sub-group diagnosis | n |
| Refraction defect | Hypermetropia | 14 |
| Myopia | 4 | |
| Astigmatism | 12 | |
| Strabismus | Esotropia | 4 |
| Exotropia | 3 | |
| Pale optic disc | 6 | |
| Other | Optic nerve coloboma | 1 |
| Traumatic optical atrophy | 1 |
Comparison of GMFM Scores
| GMFM total score | Mean±SD | p value |
| Admission | 34.02±28.95 | 0.002* |
| Discharge | 41.08±28.55 | |
| Admission | 34.02±28.95 | 0.001* |
| 1 month follow-up | 39.62±26.50 | |
| Admission | 34.02±28.95 | 0.001* |
| 3 month follow-up | 40.35±27.02 | |
| Discharge | 41.08±28.55 | 0.006* |
| 1 month follow-up | 39.62±26.50 | |
| Discharge | 41.08±28.55 | 0.007* |
| 3 month follow-up | 40.35±27.02 | |
| 1 month follow-up | 39.62±26.50 | 0.096 |
| 3 month follow-up | 40.35±27.02 |
*p<0.01